Physician profile
Heather Sheldon
NPI 1841615028
$1,452.25
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $665 · 2022: $401 · 2023: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $386.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $204.06 | 2021-2023 | Ozempic, Rybelsus |
| Lilly USA, LLC | $170.00 | 2021-2023 | Mounjaro |
| Abbvie INC. | $160.30 | 2021-2023 | |
| Glaxosmithkline, LLC. | $146.33 | 2021-2023 | Shingrix, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $138.73 | 2021-2023 | Farxiga |
| Janssen Scientific Affairs, LLC | $90.33 | 2021 | |
| Amgen INC. | $89.93 | 2021-2023 | Prolia, Evenity |
| Biohaven Pharmaceuticals, INC. | $69.25 | 2021 | |
| Exact Sciences Corporation | $67.13 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $53.35 | 2021-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $50.28 | 2022 | |
| Abbott Laboratories | $45.72 | 2023 | Freestyle Libre 2 |
| Genentech USA, INC. | $31.59 | 2021 | |
| Idorsia Pharmaceuticals US INC | $27.15 | 2022-2023 | Quviviq |
| Optinose US, INC. | $19.69 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $18.38 | 2022 | |
| Eisai INC. | $14.99 | 2021 | |
| Sanofi Pasteur INC. | $14.73 | 2023 | |
| Tris Pharma INC | $14.41 | 2022 | |
| Kaleo, INC. | $13.88 | 2021 | |
| Amneal Pharmaceuticals LLC | $12.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Sheldon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.